132 related articles for article (PubMed ID: 32693378)
21. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience.
Pollock BE; Stafford SL; Link MJ; Garces YI; Foote RL
Cancer; 2012 Feb; 118(4):1048-54. PubMed ID: 21773968
[TBL] [Abstract][Full Text] [Related]
22. Malignant Meningioma: An International Multicentre Retrospective Study.
Champeaux C; Jecko V; Houston D; Thorne L; Dunn L; Fersht N; Khan AA; Resche-Rigon M
Neurosurgery; 2019 Sep; 85(3):E461-E469. PubMed ID: 30566646
[TBL] [Abstract][Full Text] [Related]
23. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
24. Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis.
Stessin AM; Schwartz A; Judanin G; Pannullo SC; Boockvar JA; Schwartz TH; Stieg PE; Wernicke AG
J Neurosurg; 2012 Oct; 117(4):669-75. PubMed ID: 22900840
[TBL] [Abstract][Full Text] [Related]
25. Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
Bowers DC; Moskowitz CS; Chou JF; Mazewski CM; Neglia JP; Armstrong GT; Leisenring WM; Robison LL; Oeffinger KC
J Clin Oncol; 2017 May; 35(14):1570-1576. PubMed ID: 28339329
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up after surgical removal of meningioma of the inner third of the sphenoidal wing: outcome determinants and different strategies.
Talacchi A; Hasanbelliu A; D'Amico A; Regge Gianas N; Locatelli F; Pasqualin A; Longhi M; Nicolato A
Neurosurg Rev; 2020 Feb; 43(1):109-117. PubMed ID: 30187296
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and prognostic factors of WHO II and III adult spinal meningiomas: analysis of 25 cases in a single center.
Ye J; Lv G; Qian J; Zhu J; Han R; Luo C
J Neurooncol; 2016 Jun; 128(2):349-56. PubMed ID: 27056111
[TBL] [Abstract][Full Text] [Related]
28. Intracranial meningioma surgery in the ninth decade of life.
Sacko O; Sesay M; Roux FE; Riem T; Grenier B; Liguoro D; Loiseau H
Neurosurgery; 2007 Nov; 61(5):950-4; discussion 955. PubMed ID: 18091271
[TBL] [Abstract][Full Text] [Related]
29. World Health Organization grade II meningiomas.
Champeaux C; Dunn L
Acta Neurochir (Wien); 2016 May; 158(5):921-9; discussion 929. PubMed ID: 27020441
[TBL] [Abstract][Full Text] [Related]
30. Surgery for "Long-term epilepsy associated tumors (LEATs)": Seizure outcome and its predictors.
Radhakrishnan A; Abraham M; Vilanilam G; Menon R; Menon D; Kumar H; Cherian A; Radhakrishnan N; Kesavadas C; Thomas B; Sarma SP; Thomas SV
Clin Neurol Neurosurg; 2016 Feb; 141():98-105. PubMed ID: 26773699
[TBL] [Abstract][Full Text] [Related]
31. Surgery for meningioma in the elderly and long-term survival: comparison with an age- and sex-matched general population and with younger patients.
Brokinkel B; Holling M; Spille DC; Heß K; Sauerland C; Bleimüller C; Paulus W; Wölfer J; Stummer W
J Neurosurg; 2017 Apr; 126(4):1201-1211. PubMed ID: 27257838
[TBL] [Abstract][Full Text] [Related]
32. Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.
Biczok A; Jungk C; Egensperger R; von Deimling A; Suchorska B; Tonn JC; Herold-Mende C; Schichor C
J Neurooncol; 2019 Dec; 145(3):469-477. PubMed ID: 31713016
[TBL] [Abstract][Full Text] [Related]
33. Risk Factors of Preoperative and Early Postoperative Seizures in Patients with Meningioma: A Retrospective Single-Center Cohort Study.
Skardelly M; Rother C; Noell S; Behling F; Wuttke TV; Schittenhelm J; Bisdas S; Meisner C; Rona S; Tabatabai G; Roser F; Tatagiba MS
World Neurosurg; 2017 Jan; 97():538-546. PubMed ID: 27777150
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
[TBL] [Abstract][Full Text] [Related]
35. Survival in Patients with High-Grade Spinal Meningioma: An Analysis of the National Cancer Database.
Wright JM; Wright CH; Cioffi G; Raghavan A; Hdeib A; Kasliwal MK; Kruchko C; Barnholtz-Sloan JS; Sloan AE
World Neurosurg; 2019 Sep; 129():e749-e753. PubMed ID: 31203074
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
[TBL] [Abstract][Full Text] [Related]
37. Clinical and histopathological predictors of outcome in malignant meningioma.
Maier AD; Bartek J; Eriksson F; Ugleholdt H; Juhler M; Broholm H; Mathiesen TI
Neurosurg Rev; 2020 Apr; 43(2):643-653. PubMed ID: 30868425
[TBL] [Abstract][Full Text] [Related]
38. Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article.
Hasseleid BF; Meling TR; Rønning P; Scheie D; Helseth E
J Neurosurg; 2012 Dec; 117(6):999-1006. PubMed ID: 23061394
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas.
Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
